Pipeline Strategy

Create a Robust Product Pipeline Through Devising a Solid Pipeline Strategy

ZS Associates helps pharmaceutical companies of all sizes build a commercially successful product portfolio through well-considered pipeline investment decisions. We typically work with headquarters marketing, brand and research & development executives to determine where to put their companies’ limited new product development resources and how to substantially improve the odds of success years before and up to launch. Our services fall into five categories:

1. Disease area strategy – to determine the most promising therapy areas for a life sciences company, ones that are in line with its corporate strategy
2. Business development & licensing strategy – to identify potential acquisitions and licensing partners whose products can accelerate time to market
3. Portfolio strategy – to calculate an acceptable risk vs. return in the product portfolio
4. Development strategy – to develop products that meet market needs in a superior way
5. Launch strategy – to make sure marketing and sales activities and plans are synchronized to successfully create market demand

Some clients have used our services in one or two of the above areas; others have used us to devise strategies for most or all of the areas for a specific product. In all, we have helped 39 of the 40 largest life sciences companies bring to market hundreds of products in more than 150 therapy areas.